News | January 05, 2010

FDA Says RFID Devices Cause Malfunctions in Pacemakers, ICDs

January 6, 2010 – The FDA, in collaboration with major implantable pacemaker and implantable cardioverter-defibrillator (ICD) manufacturers, demonstrated the effects of emissions from radio frequency identification (RFID) readers on common implantable cardiac devices. According to research published in the January edition of the HeartRhythm Journal, the effects may cause increasing complications as RFID use expands in the medical device field.

The study, which looked at the electromagnetic interference susceptibility of 15 pacemakers and 15 ICDs caused by exposure to 13 RFID readers, concluded that low frequency RFID readers may pose the greatest risk to pacemakers and ICDs. While modern pacemakers and ICDs use filters to minimize susceptibility to higher-frequency signals, there is limited filtering of low frequency signals due to the design constraints of both pacemakers and ICDs.

The in vitro testing concluded that low frequency RFID readers caused reactions in 67 percent of pacemaker and 47 percent of ICD tests. During tests at multiple separation distances between RFID reader and the implanted device, ranging from 2.5 to 60 cm, the RFID readers’ emissions creating the most interference were recorded at the shortest distance where the exposure is highest. The study indicates that for most practical exposure situations a minimum separation distance of 2.5 cm may not be possible; however, there are medical applications where 2.5 cm separation distance is feasible.

“We do not believe the current situation reveals an urgent public health risk,” said lead author Seth J. Seidman, research electrical engineer for the FDA’s Center for Devices of Radiological Health. “However, we are concerned that the continued proliferation of RFID without taking electromagnetic interference into consideration could cause clinically significant events for patients.”

Among the reactions from pacemakers and ICDs includes pacing inhibition, inappropriate pacing, noise reversion mode, changed pacing rates, inappropriate delivery of anti-tachycardia pacing, inappropriate high-voltage shocks and device programming change. Although in vitro testing demonstrated the potential for pacemaker and ICD interference, the FDA has not received any incident reports of electromagnetic interference caused by any RFID system.

Seidman said while clinical exposure to RFID readers is uncommon, advances in medical applications using RFID may lead to increased use in patient care. To mitigate pacemaker and ICD electromagnetic interference from RFID readers, implant manufacturers and the RFID industry must work to develop industry requirements and design future devices appropriately.

For more information: www.heartrhythmjournal.com

Related Content

Mexican Doctors Safely Reuse Donated Pacemakers After Sterilization

Mexican government reports conclude more than half of the population does not have access to social security or private insurance that covers a pacemaker implant, and 44 percent live in poverty. Recycling donated, explanted pacemakers offers a new option for these patients.

News | Pacemakers| November 10, 2017
Mexican doctors have safely reused donated pacemakers after sterilization, shows a study presented at the 30th Mexican...
Pacemakers and Other Cardiac Devices Can Help Solve Forensic Cases
News | Pacemakers| June 20, 2017
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the European...
Videos | Pacemakers| May 23, 2017
Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospita
micra leadless pacemaker
Feature | Pacemakers| May 16, 2017
May 16, 2017 - The preliminary results for the Medtronic Micra Transcatheter Pacing System (TPS) Post-Approval Regist
Videos | Pacemakers| May 16, 2017
This video, provided by Medtronic, demonstrates the implantation of Micra transcatheter pacing system (TPS).
closed loop stimulation, DDD-CLS, ACC17, SPAIN trial
Feature | Pacemakers| March 22, 2017
March 22, 2017 — Patients with recurrent fainting episodes (syncope) who received a pacemaker delivering a pacing pro
Micra leadless pacemaker, CMS, medicare reimbursement
News | Pacemakers| March 10, 2017
March, 10, 2017 - Medtronic announced that the U.S.
Medtronic, Micra TPS pacemaker, transcatheter pacing system, global clinical trial, one-year results, ESC 2016
News | Pacemakers| August 29, 2016
August 29, 2016 — Medtronic plc announced new long-term results from the Medtronic Micra Transcatheter Pacing System
Medtronic, Micra TPS pacemaker, Global Clinical Trial, Cardiostim 2016
News | Pacemakers| June 09, 2016
Medtronic plc announced new results from the Medtronic Micra Transcatheter Pacing System (TPS) Global Clinical Trial in...
Medtronic, Micra TPS, transcatheter pacing system, pacemaker, Jersey Shore University Medical Center, New Jersey first
News | Pacemakers| June 06, 2016
Jersey Shore University Medical Center, part of Meridian CardioVascular Network, is the first hospital in New Jersey to...
Overlay Init